Unknown

Dataset Information

Predicted vs Observed Metastasis-Free Survival in Individuals With Uveal Melanoma.


ABSTRACT:

Importance

Accuracy of the predicted metastasis-free survival (MFS) by a commercially available gene expression profiling (GEP) test is not known.

Objective

To compare the predicted MFS with the observed MFS in patients in this cohort and with those in published studies (published MFS, meta-analysis).

Design, setting, and participants

This cohort study included consecutive patients from the University of Iowa and Cleveland Clinic who were diagnosed with uveal melanoma who underwent prognostic fine-needle aspiration biopsy at the time of primary treatment. Patients were recruited from December 2012 to December 2020. The predicted MFS for patients was extracted from the GEP report. The observed MFS was defined as time to metastasis. Cox proportional hazards models were

SUBMITTER: Singh AD 

PROVIDER: S-EPMC9305597 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature